Paclitaxel Injection, Solution
Product Images NDC 68083-180

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 68083-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-10 (Image10)

Packaging label for Paclitaxel Injection, USP 30 mg/5 mL (6 mg/mL) intravenous injection solution in a multiple dose vial. The label shows dosage strength, storage instructions, and warnings including it is a cytotoxic agent requiring dilution before IV infusion. Manufactured by Gland Pharma Limited, India. Contains details like NDC 68083-178-01 and vial size 1x5 mL.*

FDA Label Image

Image-11 (Image11)

Packaging label for Paclitaxel Injection, USP 100 mg/16.7 mL (6 mg/mL) sterile solution for intravenous use. The label indicates a multiple dose vial, with cautionary notes about dilution prior to IV infusion and cytotoxic agent warning. Manufactured by Gland Pharma Limited, India. Includes storage instructions and ingredient details.*

FDA Label Image

Image-12 (Image12)

Packaging label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) solution for intravenous injection. The label indicates a sterile multiple dose vial, manufactured by Gland Pharma Limited, India. It includes storage, handling instructions, and warnings such as the need for dilution prior to IV infusion and cytotoxic agent caution. The label displays NDC 68083-180-01 and spaces for lot, expiration, and barcode.*

FDA Label Image

Paclitaxel-image1 (Paclitaxel Image1)

Chemical structure of paclitaxel, the active ingredient in PACLITAXEL PACLITAXEL injection, solution 6 mg/mL by Gland Pharma Limited.*

FDA Label Image

Paclitaxel-image2 (Paclitaxel Image2)

A survival curve chart with proportion surviving on the Y-axis and years on the X-axis, comparing two groups labeled Cc and Tc. The chart includes the number at risk at different years and an inset table showing sample sizes, event numbers, and a hazard ratio with confidence intervals.*

FDA Label Image

Paclitaxel-image3 (Paclitaxel Image3)

A Kaplan-Meier survival curve graph illustrating the proportion surviving over a five-year period for two groups labeled 'Cc' and 'Tc'. The graph includes a small inset table showing the number of participants (N), number of events, and hazard ratio (HR) with confidence interval (CI) comparing the groups.*

FDA Label Image

Paclitaxel-image4 (Paclitaxel Image4)

A Kaplan-Meier survival curve chart showing the proportion of patients disease-free over a four-year period. It compares two groups labeled AC and AC+T, with AC+T showing a higher proportion disease-free. The chart includes numerical data for number of events, hazard ratio, and number at risk at yearly intervals for both groups.*

FDA Label Image

Paclitaxel-image5 (Paclitaxel Image5)

A survival curve graph comparing the proportion surviving over a period of 0 to 4 years between two treatment groups labeled AC and AC+T. The graph includes a table showing number of subjects, events, hazard ratio (HR), and 95% confidence interval (CI) for each group, as well as a table indicating the number at risk at yearly intervals.*

FDA Label Image

Paclitaxel-image6 (Paclitaxel Image6)

A Kaplan-Meier curve chart depicting the proportion of disease-free patients over a period of four years. The graph compares two groups labeled "AC" and "AC+T," showing the survival proportion on the vertical axis and time in years on the horizontal axis. The chart includes number at risk tables and hazard ratio data for both groups.*

FDA Label Image

Paclitaxel-image7 (Paclitaxel Image7)

A survival curve chart showing the proportion of patients disease-free over a span of 4 years comparing two groups: AC and AC+T. The graph includes the number of patients, events, hazard ratio, and confidence interval for each group, as well as the number of patients at risk at various time points.*

FDA Label Image

Paclitaxel-image8 (Paclitaxel Image8)

A line graph showing the proportion of patients who remain disease-free over a period of 4 years, comparing two treatment groups labeled AC and AC+T. The x-axis represents time in years, and the y-axis shows the proportion disease-free. The graph includes a table inset with sample sizes, event numbers, hazard ratio, confidence intervals, and numbers at risk for each group over time.*

FDA Label Image

Paclitaxel-image9 (Paclitaxel Image9)

A Kaplan-Meier survival curve chart showing the proportion of disease-free patients over a period of 4 years. The chart compares two groups labeled AC and AC+T, with accompanying risk table and hazard ratio data indicating event counts and statistical comparison between the groups over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.